Biohaven Ltd (BHVN)

$15.81 +0.30 (1.93%)
Market Cap 1.67B
Revenue (ttm) 0.00
Net Income (ttm) -846.42M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 1.91
Volume 1,834,400
Avg Vol 2,305,976
Day's Range N/A - N/A
Shares Out 105.79M
Stochastic %K 85%
Beta 1.03
Analysts Strong Sell
Price Target $46.50

Company Profile

Biohaven Ltd. discovers, develops, and commercializes therapies for immunology, neuroscience, and oncology worldwide. The company develops troriluzole, which is in Phase 3 trial for the treatment of neurological and neuropsychiatric illnesses; taldefgrobep alfa, which is in Phase 3 clinical trial for the treatment of spinal muscular atrophy and obesity; BHV-7000, a candidate in Phase 3 clinical trial for the treatment of focal and generalized epilepsy, and major depressive disorder; BHV-2100 tha...

Industry: Biotechnology
Sector: Healthcare
Phone: 203 404 0410
Address:
215 Church Street, New Haven, United States
highnihilism
highnihilism Oct. 6 at 3:45 AM
$BHVN Biohaven Ltd. 15.81 +1.9% | 602 trades | total $783.8K | 90-day avg $603.9K × 1.30 call $393.2K | put $390.7K | 98% single-leg, 2% multi-leg, 0% contingent
0 · Reply
HamBoneXoXo
HamBoneXoXo Oct. 4 at 2:37 AM
$BHVN Summary charts are helpful in keeping the focus while kids are yelling and spouse is for some unknown reason upset with you.
0 · Reply
Ohzipit
Ohzipit Oct. 3 at 8:16 PM
$BHVN RJ strong buy price target $75.
1 · Reply
ChrisBAB
ChrisBAB Oct. 3 at 8:08 PM
$BHVN Next stop $18. See you next week!
0 · Reply
HamBoneXoXo
HamBoneXoXo Oct. 3 at 2:56 PM
$BHVN They accumulated in 13-15 and now letting it go
0 · Reply
sellthedip1
sellthedip1 Oct. 3 at 2:10 PM
$BHVN not bad day!
1 · Reply
SweepCastApp
SweepCastApp Oct. 3 at 6:52 AM
$BHVN: Unusual Options Activity Alerted PUT flow observed 141x contracts at Strike price of $15 Exp on 12/18/2026 with Premium of $103K and showing BEARISH Sentiment
0 · Reply
EmoDaddy
EmoDaddy Oct. 3 at 2:50 AM
$BHVN shaping up.
0 · Reply
FloatTrip
FloatTrip Oct. 2 at 10:52 PM
$BHVN Holding Long. Big pipeline with BHVN, it's a safe Bio to put a good chunk of money into. If we miss on an approval or good data on one readout, ..it doesn't do the tremendous damage to the share price like most other Bio companies have happen to them. The Pipeline, as big as it is, keeps the share price stable if bad news ever happens. We had a miss on the OCD drug, we took a 1-2 dollar drop, and it was back to $15 about two weeks later. Good things to come in the very near future here!
0 · Reply
Timefortendies77
Timefortendies77 Oct. 2 at 11:47 AM
$BHVN This will prob be one of the best BIOs of 2026 if they hit on Epilepsy.
1 · Reply
Latest News on BHVN
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 12, 2025 in Biohaven Ltd. Lawsuit – BHVN

Sep 10, 2025, 3:39 PM EDT - 25 days ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 12, 2025 in Biohaven Ltd. Lawsuit – BHVN

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven

Sep 6, 2025, 10:03 AM EDT - 4 weeks ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven

Aug 28, 2025, 6:55 PM EDT - 5 weeks ago

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven

Biohaven: Despite Troriluzole Program Delay, FDA Review On Track For Q4 2025

Aug 25, 2025, 8:00 AM EDT - 5 weeks ago

Biohaven: Despite Troriluzole Program Delay, FDA Review On Track For Q4 2025

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven

Aug 22, 2025, 10:05 AM EDT - 6 weeks ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Biohaven

Biohaven Reports Second Quarter 2025 Financial Results and Recent Business Developments

Aug 11, 2025, 7:00 AM EDT - 7 weeks ago

Biohaven Reports Second Quarter 2025 Financial Results and Recent Business Developments

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 12, 2025 in Biohaven Ltd. Lawsuit - BHVN

Aug 4, 2025, 8:45 AM EDT - 2 months ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of September 12, 2025 in Biohaven Ltd. Lawsuit - BHVN

Law Offices of Frank R. Cruz Encourages Biohaven Ltd.

Jul 18, 2025, 12:06 PM EDT - 2 months ago

Law Offices of Frank R. Cruz Encourages Biohaven Ltd.

Law Offices of Howard G. Smith Encourages Biohaven Ltd.

Jul 18, 2025, 12:00 PM EDT - 2 months ago

Law Offices of Howard G. Smith Encourages Biohaven Ltd.

Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Biohaven Ltd. (BHVN)

Jul 15, 2025, 10:46 AM EDT - 2 months ago

Gainey McKenna & Egleston Announces a Class Action Lawsuit Has Been Filed Against Biohaven Ltd. (BHVN)

Bexorg Announces Research Collaboration with Biohaven Leveraging Its Novel AI-Driven Whole-Brain Discovery Platform to Enhance CNS Drug Development

Jun 10, 2025, 2:00 PM EDT - 4 months ago

Bexorg Announces Research Collaboration with Biohaven Leveraging Its Novel AI-Driven Whole-Brain Discovery Platform to Enhance CNS Drug Development

Biohaven Enrolls First Patient into Phase 2/3 Trial in Early Parkinson's Disease, Targeting Neuroinflammation with Novel Brain-Penetrant TYK2/JAK1 Inhibitor

May 29, 2025, 7:01 AM EDT - 4 months ago

Biohaven Enrolls First Patient into Phase 2/3 Trial in Early Parkinson's Disease, Targeting Neuroinflammation with Novel Brain-Penetrant TYK2/JAK1 Inhibitor

Biohaven Highlights Innovation and Advancement Across MoDE and TRAP Degrader Platform at R&D Day, Announcing Positive TRAP Degrader Data Achieving > 80% Sustained Reductions in Galactose-Deficient IgA1 (Gd-IgA1) with Potential First-in-Class BHV-1400 for IgA Nephropathy (IgAN)

May 28, 2025, 3:00 PM EDT - 4 months ago

Biohaven Highlights Innovation and Advancement Across MoDE and TRAP Degrader Platform at R&D Day, Announcing Positive TRAP Degrader Data Achieving > 80% Sustained Reductions in Galactose-Deficient IgA1 (Gd-IgA1) with Potential First-in-Class BHV-1400 for IgA Nephropathy (IgAN)

Biohaven Presents Oncology Program Updates and Preliminary Clinical Data Showcasing Innovative Trop2 and FGFR3 Antibody Drug Conjugates (ADCs) Incorporating Novel TopoIx Payload with Potential to Treat a Wide Variety of Tumors

May 28, 2025, 7:30 AM EDT - 4 months ago

Biohaven Presents Oncology Program Updates and Preliminary Clinical Data Showcasing Innovative Trop2 and FGFR3 Antibody Drug Conjugates (ADCs) Incorporating Novel TopoIx Payload with Potential to Treat a Wide Variety of Tumors

Why Is Biohaven Stock Falling On Thursday?

May 15, 2025, 1:22 PM EDT - 5 months ago

Why Is Biohaven Stock Falling On Thursday?

FDA Extends PDUFA Date of Biohaven's Troriluzole NDA for Rare Disease Spinocerebellar Ataxia

May 14, 2025, 6:43 PM EDT - 5 months ago

FDA Extends PDUFA Date of Biohaven's Troriluzole NDA for Rare Disease Spinocerebellar Ataxia

Biohaven Reports First Quarter 2025 Financial Results and Recent Business Developments

May 12, 2025, 4:05 PM EDT - 5 months ago

Biohaven Reports First Quarter 2025 Financial Results and Recent Business Developments

Biohaven Is Now A Compelling Contrarian Play Before Troriluzole's FDA Verdict

May 5, 2025, 8:00 AM EDT - 5 months ago

Biohaven Is Now A Compelling Contrarian Play Before Troriluzole's FDA Verdict

Biohaven Announces Investment up to $600 Million by Oberland Capital

Apr 28, 2025, 7:30 AM EDT - 5 months ago

Biohaven Announces Investment up to $600 Million by Oberland Capital

BHVN Investors Have Opportunity to Join Biohaven Ltd. Fraud Investigation with the Schall Law Firm

Apr 15, 2025, 9:10 AM EDT - 6 months ago

BHVN Investors Have Opportunity to Join Biohaven Ltd. Fraud Investigation with the Schall Law Firm

Biohaven Presents Data Across Innovative Neuroscience Portfolio at the 2025 American Academy of Neurology (AAN) Annual Meeting

Apr 5, 2025, 9:00 AM EDT - 6 months ago

Biohaven Presents Data Across Innovative Neuroscience Portfolio at the 2025 American Academy of Neurology (AAN) Annual Meeting

highnihilism
highnihilism Oct. 6 at 3:45 AM
$BHVN Biohaven Ltd. 15.81 +1.9% | 602 trades | total $783.8K | 90-day avg $603.9K × 1.30 call $393.2K | put $390.7K | 98% single-leg, 2% multi-leg, 0% contingent
0 · Reply
HamBoneXoXo
HamBoneXoXo Oct. 4 at 2:37 AM
$BHVN Summary charts are helpful in keeping the focus while kids are yelling and spouse is for some unknown reason upset with you.
0 · Reply
Ohzipit
Ohzipit Oct. 3 at 8:16 PM
$BHVN RJ strong buy price target $75.
1 · Reply
ChrisBAB
ChrisBAB Oct. 3 at 8:08 PM
$BHVN Next stop $18. See you next week!
0 · Reply
HamBoneXoXo
HamBoneXoXo Oct. 3 at 2:56 PM
$BHVN They accumulated in 13-15 and now letting it go
0 · Reply
sellthedip1
sellthedip1 Oct. 3 at 2:10 PM
$BHVN not bad day!
1 · Reply
SweepCastApp
SweepCastApp Oct. 3 at 6:52 AM
$BHVN: Unusual Options Activity Alerted PUT flow observed 141x contracts at Strike price of $15 Exp on 12/18/2026 with Premium of $103K and showing BEARISH Sentiment
0 · Reply
EmoDaddy
EmoDaddy Oct. 3 at 2:50 AM
$BHVN shaping up.
0 · Reply
FloatTrip
FloatTrip Oct. 2 at 10:52 PM
$BHVN Holding Long. Big pipeline with BHVN, it's a safe Bio to put a good chunk of money into. If we miss on an approval or good data on one readout, ..it doesn't do the tremendous damage to the share price like most other Bio companies have happen to them. The Pipeline, as big as it is, keeps the share price stable if bad news ever happens. We had a miss on the OCD drug, we took a 1-2 dollar drop, and it was back to $15 about two weeks later. Good things to come in the very near future here!
0 · Reply
Timefortendies77
Timefortendies77 Oct. 2 at 11:47 AM
$BHVN This will prob be one of the best BIOs of 2026 if they hit on Epilepsy.
1 · Reply
sellthedip1
sellthedip1 Oct. 1 at 10:11 PM
$BHVN
0 · Reply
SweepCastApp
SweepCastApp Oct. 1 at 8:02 PM
$BHVN: Unusual Options Activity Alerted PUT flow observed 250x contracts at Strike price of $10 Exp on 01/16/2026 with Premium of $80K and showing BEARISH Sentiment
0 · Reply
HamBoneXoXo
HamBoneXoXo Oct. 1 at 5:03 PM
$BHVN I hope ST doesn’t shut us down for inactivity!
0 · Reply
HamBoneXoXo
HamBoneXoXo Sep. 30 at 9:06 PM
$BHVN ReZeeLeeAnt 😘
0 · Reply
Brianum2011
Brianum2011 Sep. 30 at 6:29 PM
$BHVN Thinking to buy 10k worth of stock starting tomorrow since tomorrow is when q4 starts and troriluzole data for sca data should be released anytime now
0 · Reply
sellthedip1
sellthedip1 Sep. 30 at 5:33 PM
$BHVN
0 · Reply
dingetdong
dingetdong Sep. 29 at 10:28 PM
$BHVN
0 · Reply
highnihilism
highnihilism Sep. 29 at 9:21 PM
$BHVN: 1.4K trades, $3.1M vs $587K avg (5.3x). Bullish skew: $2.6M calls/$529K puts. Only 21% single-leg (heavy spreads). $SBSW: 2.1K trades, $2.7M vs $1.3M avg (2.2x). Bullish skew: $2.6M calls/$160K puts. 82% single-leg. $PPLT: 963 trades, $2.7M vs $863K avg (3.1x). Bullish skew: $2.5M calls/$138K puts. 90% single-leg. $MA: 2.2K trades, $4.8M vs $9.9M avg (0.49x). Balanced skew: $2.5M calls/$2.3M puts. Only 44% single-leg.
0 · Reply
sellthedip1
sellthedip1 Sep. 29 at 10:17 AM
$BHVN
0 · Reply
SweepCastApp
SweepCastApp Sep. 28 at 11:05 AM
$BHVN: Unusual Options Activity Alerted CALL flow observed 500x contracts at Strike price of $15 Exp on 04/17/2026 with Premium of $330K and showing BEARISH Sentiment
0 · Reply
SweepCastApp
SweepCastApp Sep. 27 at 12:51 PM
$BHVN: TRADE CALL flow observed 500 @ 6.60 Strike 15 Exp 04/17/2026 Premium $330.0K Sentiment BEARISH
0 · Reply
sellthedip1
sellthedip1 Sep. 26 at 8:30 PM
$BHVN Notable Friday Option Activity: BHVN, F, G | Nasdaq https://www.nasdaq.com/articles/notable-friday-option-activity-bhvn-f-g
0 · Reply